Purchase Order 75F40122P00286
Award Date 7/25/22
Potential Completion Date 12/30/22
Potential Value $79K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02453, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price purchase order contract was awarded by the Food and Drug Administration (FDA) to Olink Proteomics AB, a foreign-owned for-profit manufacturer based in Sweden. The $75,718 contract is for the provision of proteomics analysis services, including the analysis of plasma samples to support biomedical research across disease areas such as cancer, cardiovascular disease, infectious disease, and COVID-19. Olink has previously provided similar services to federal agencies like the...
- This is a $147,501.31 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract, which has no set-aside designation, is for the acquisition of Olink's O-Link System and reagents. Olink Proteomics specializes in protein biomarker discovery solutions and has provided a variety of proteomics instruments, assay kits, and analysis services to support government research efforts,...
- The Food and Drug Administration (FDA) awarded a $94,500 firm fixed-price purchase order to Olink Proteomics AB, a foreign-owned manufacturer of protein biomarker analysis technologies and services. The contract is for quantitative proteomics measurement of cardiotoxicity biomarkers in 150 human plasma samples using Olink's proprietary Explore 1536 multiplex analysis platform. This purchase order was awarded without a set-aside and is not associated with a larger contract vehicle. Olink...
- The Department of Health and Human Services Food and Drug Administration awarded a $87,620 purchase order to Olink Proteomics Inc. of Waltham, Massachusetts. The firm fixed price contract is for quantitative proteomics measurement of 100 human COVID-19 plasma samples. Performance will take place in Waltham from July 18, 2023 through December 8, 2023. The solicitation sought quantitative proteomics measurement of the specified plasma samples, as described in the attached combined synopsis and...
- The U.S. Food and Drug Administration (FDA) awarded a $106,675.00 firm fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, for a proteomic analysis of cancer patient plasma samples. The contract, which has no set-aside designation, will be performed at Olink's facility in Waltham, Massachusetts and involves the comprehensive analysis of over 5,000 proteins across 100 plasma samples using Olink's advanced multiplex immunoassay...
- The U.S. Food and Drug Administration (FDA) awarded a $99,413.00 firm-fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, to conduct cardiotoxicity biomarker analysis on plasma samples from cancer patients. The contract has an ultimate completion date of September 29, 2025. This contract was awarded under a competitive solicitation that was set aside for small businesses under NAICS code 541380 - Testing Laboratories and Services....
- This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company. The contract is for the procurement of Olink Explore HT Reagent Kits, specialized biological and reagent materials used in advanced proteomics research. The contract has a ceiling value of $24,961.31 and a period of performance through September 17, 2025. Olink...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Olink Proteomics Inc., a foreign-owned for-profit organization, in the amount of $113,936.00. The award is for the delivery of Olink's integrated fluidic circuits and reagent kits to support the Viral Pathogenesis and Evolution Section's research into the development of universal influenza and SARS-CoV-2 vaccines. The...
- This firm-fixed-price purchase order was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $13,184 contract is for a service agreement with a completion date of September 21, 2025. Olink Proteomics provides a range of proteomics instruments, reagent kits, integrated fluidic circuits, analysis services, and biological products to support biomedical...
- This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for the provision of the OLINK SIGNATURE Q100 STARTER KIT AND REAGENTS. The contract is a firm-fixed-price purchase order with a potential value of $187,601.80 and a completion date of August 22, 2023. No set-aside designation was used for this award. Olink Proteomics has received...